COMPASS Pathways plc Insider Transactions
COMPASS Pathways plc Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 19,853 @ $10.59 | $210,315 | 4,144,994 | 02/06/2024 | 02/08/2024 | |
Malievskaia Ekaterina
Director, 10 percent owner: |
Sell | 25,750 @ $8.35 | $215,033 | 4,169,745 | 01/22/2024 | 01/23/2024 | |
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 25,750 @ $8.35 | $215,033 | 4,169,745 | 01/22/2024 | 01/23/2024 | |
Malievskaia Ekaterina
Director, 10 percent owner: |
Sell | 20,206 @ $7.99 | $161,448 | 4,195,495 | 01/19/2024 | 01/23/2024 | |
Malievskaia Ekaterina
Director, 10 percent owner: |
Sell | 20,205 @ $7.99 | $161,440 | 4,198,154 | 01/19/2024 | 01/23/2024 | |
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 20,206 @ $7.99 | $161,448 | 4,195,495 | 01/19/2024 | 01/23/2024 | |
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 20,205 @ $7.99 | $161,440 | 4,198,154 | 01/19/2024 | 01/23/2024 | |
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 21,758 @ $8.74 | $190,226 | 4,218,359 | 01/03/2024 | 01/04/2024 | |
Malievskaia Ekaterina
Director, 10 percent owner: |
Sell | 21,758 @ $8.74 | $190,226 | 4,218,359 | 01/03/2024 | 01/04/2024 | |
Malievskaia Ekaterina
Director, 10 percent owner: |
Sell | 25,750 @ $9.00 | $231,706 | 4,237,459 | 01/02/2024 | 01/04/2024 | |
Goldsmith George Jay
Director, 10 percent owner: |
Sell | 25,750 @ $9.00 | $231,706 | 4,237,459 | 01/02/2024 | 01/04/2024 |
COMPASS Pathways plc FAQ's
The list of insiders at COMPASS Pathways plc includes Goldsmith George Jay, Malievskaia Ekaterina, ATAI Life Sciences N.V..
Insiders have sold a total of 3.36 M COMPASS Pathways plc shares in the last 12 months for a total of 22.64 M sold.
The following insiders have sold COMPASS Pathways plc shares in the last 12 months: Goldsmith George Jay ($3.28 M), Malievskaia Ekaterina ($3.28 M), ATAI Life Sciences N.V. ($16.09 M),